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Summary. Following injury, tissue repair process takes 
place involving inflammation, granulation tissue 
formation and scar constitution. Granulation tissue 
develops from the connective tissue surrounding the 
damaged area and contains vessels, inflammatory cells, 
fibroblasts and myofibroblasts. Myofibroblasts play an 
important role in many tissue injuries and fibro- 
contractive diseases. The process of normal wound 
repair after tissue injury follows a closely regulated 
sequence including the activation and the proliferation of 
fibroblastic cells. In pathological situations, the normal 
resolution stages are abrogated and the proliferation 
of myofibroblasts continues, inducing excessive 
accumulation of extracellular matrix. The differentiation 
of fibroblastic cells into myofibroblasts is an early event 
in the development of tissue fibrosis. Myofibroblastic 
cells express smooth muscle cytoskeletal markers (a- 
smooth muscle actin in particular) and participate 
actively in the production of extracellular matrix. The 
evaluation of myofibroblast differentiation in renal 
biopsies would be useful for histopathologists to 
appreciate the intensity of tissue injury and particularly 
to predict the long term outcome of some nephropathies. 
Immunohistochemical studies for a-smooth muscle actin 
should be made systematically in renal tissue biopsies. 
Myofibroblastic differentiation appears to play a 
significant role in the progression of renal failure and 
seems to be a useful marker of progressive disease. 
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introduction 
During tissue repair and fibrocontractive diseases, 
fibroblastic cells participating in granulation tissue 
development acquire  some morphological and 
biochemical features of smooth muscle (SM) cells 
(Schiirch et al., 1992). These modified fibroblastic cells, 
called myofibroblasts, express SM cytoskeletal markers 
(a-SM actin in particular) and are involved in tissue 
contraction. Furthermore, they participate actively in the 
production of extracellular matrix (Desmoulikre and 
Gabbiani, 1996). Since 1971, when myofibroblastic cells 
were first described by Gabbiani et al., it has been shown 
that these cells play a major role during normal tissue 
repair but also in pathological processes such as fibrosis 
in various organs (e.g. lungs, liver, and kidneys). 
Fibrosis is a common consequence of abnormal healing 
process in response to various exogenous insults 
(physical, chemical or biological). The mechanisms of 
induction and progression of fibrosis are complex and 
involve multiple cellular interactions via cytokines and 
growth factors. 
Renal fibrosis is the final common pathway for 
almost all forms of kidney disease that progress to end 
stage of renal failure. Progressive renal disease involves 
both glomemlar and interstitial processes. In glomeruli, 
sclerosis  occurs  with progressive deposition of 
extracellular matrix components that reduce the filtration 
surface area. Most research on progressive glomerular 
disease has focused on changes in glomerulus. However, 
tubulointerstitial changes correlate closely with the loss 
of renal function in patients with glomerular diseases 
(Bohle et al., 1996). In several glomerular diseases such 
as membranous nephropathy, endocapillary acute 
glomerulonephritis or diabetic nephropathy, the long 
term renal outcome correlates strongly with the 
development of interstitial fibrosis (Austin et al., 1994; 
Bohle et al., 1996; Ziyadeh, 1996). During experimental 











